Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)/delta.

PubWeight™: 2.50‹?› | Rank: Top 2%

🔗 View Article (PMID 2850650)

Published in Vet Pathol on November 01, 1988

Authors

G B Baskin1, M Murphey-Corb, E A Watson, L N Martin

Author Affiliations

1: Delta Regional Primate Research Center, Tulane University, Covington, LA.

Articles citing this

Cryptosporidiosis. Clin Microbiol Rev (1991) 4.73

Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J Virol (1996) 4.29

Progression to AIDS in the absence of a gene for vpr or vpx. J Virol (1995) 3.96

Significance of premature stop codons in env of simian immunodeficiency virus. J Virol (1989) 3.60

Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J Virol (1989) 3.43

Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J Virol (1993) 3.37

Mosaic genome structure of simian immunodeficiency virus from west African green monkeys. EMBO J (1994) 3.19

Vaccine protection against simian immunodeficiency virus infection. Proc Natl Acad Sci U S A (1989) 3.13

Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. J Virol (1995) 2.96

A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. J Virol (1997) 2.46

Macrophage-tropic variants of SIV are associated with specific AIDS-related lesions but are not essential for the development of AIDS. Am J Pathol (1991) 2.38

Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J Virol (2000) 2.26

Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals. J Virol (1990) 2.04

Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys. Am J Pathol (1991) 1.93

Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus. Am J Pathol (1994) 1.91

Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection. J Virol (1990) 1.59

Wide range of viral load in healthy african green monkeys naturally infected with simian immunodeficiency virus. J Virol (2000) 1.55

Multiple viral determinants contribute to pathogenicity of the acutely lethal simian immunodeficiency virus SIVsmmPBj variant. J Virol (1993) 1.49

Intrinsic susceptibility of rhesus macaque peripheral CD4(+) T cells to simian immunodeficiency virus in vitro is predictive of in vivo viral replication. J Virol (2000) 1.47

Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDS. J Virol (2007) 1.44

Identification of an Enterocytozoon bieneusi-like microsporidian parasite in simian-immunodeficiency-virus-inoculated macaques with hepatobiliary disease. Am J Pathol (1997) 1.38

Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes. Am J Pathol (1993) 1.37

Antiviral antibodies are necessary for control of simian immunodeficiency virus replication. J Virol (2007) 1.37

Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques. J Virol (1996) 1.31

Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques. J Virol (2004) 1.25

Plateau levels of viremia correlate with the degree of CD4+-T-cell loss in simian immunodeficiency virus SIVagm-infected pigtailed macaques: variable pathogenicity of natural SIVagm isolates. J Virol (2005) 1.23

Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS. J Virol (2003) 1.19

Monocyte adhesion to endothelium in simian immunodeficiency virus-induced AIDS encephalitis is mediated by vascular cell adhesion molecule-1/alpha 4 beta 1 integrin interactions. Am J Pathol (1994) 1.14

Malignant lymphomas in cynomolgus monkeys infected with simian immunodeficiency virus. Am J Pathol (1990) 1.04

Direct inoculation of simian immunodeficiency virus from sooty mangabeys in black mangabeys (Lophocebus aterrimus): first evidence of AIDS in a heterologous African species and different pathologic outcomes of experimental infection. J Virol (2004) 1.01

Pneumocystis colonization in immunocompetent and simian immunodeficiency virus-infected cynomolgus macaques. J Infect Dis (2009) 0.99

Expression of simian immunodeficiency virus nef in immune cells of transgenic mice leads to a severe AIDS-like disease. J Virol (2002) 0.97

Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo. J Virol (2006) 0.97

Immunodeficiency in the absence of high viral load in pig-tailed macaques infected with Simian immunodeficiency virus SIVsun or SIVlhoest. J Virol (2005) 0.96

Association of FAK activation with lentivirus-induced disruption of blood-brain barrier tight junction-associated ZO-1 protein organization. J Neurovirol (2009) 0.96

Induction of disseminated Mycobacterium avium in simian AIDS is dependent upon simian immunodeficiency virus strain and defective granuloma formation. Am J Pathol (2001) 0.95

Identification of enteropathogenic Escherichia coli in simian immunodeficiency virus-infected infant and adult rhesus macaques. J Clin Microbiol (2001) 0.93

Simian immunodeficiency virus infection of macaque bone marrow macrophages correlates with disease progression in vivo. Am J Pathol (1991) 0.90

T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route. Proc Natl Acad Sci U S A (1993) 0.89

Biomedical consequences of alcohol use disorders in the HIV-infected host. Curr HIV Res (2014) 0.88

Antibodies to human and non-human primate cellular and culture medium components in macaques vaccinated with the simian immunodeficiency virus. Immunology (1994) 0.88

Effects of U-75875, a peptidomimetic inhibitor of retroviral proteases, on simian immunodeficiency virus infection in rhesus monkeys. Antimicrob Agents Chemother (1994) 0.88

Oral administration of the nucleoside EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine) provides rapid suppression of HIV viremia in humanized mice and favorable pharmacokinetic properties in mice and the rhesus macaque. Antimicrob Agents Chemother (2015) 0.88

S100β as a novel and accessible indicator for the presence of monocyte-driven encephalitis in AIDS. Neuropathol Appl Neurobiol (2012) 0.87

Effects of alcohol consumption on antigen-specific cellular and humoral immune responses to SIV in rhesus macaques. J Acquir Immune Defic Syndr (2013) 0.87

Human immunodeficiency virus-infected multinucleated histiocytes in oropharyngeal lymphoid tissues from two asymptomatic patients. Am J Pathol (1991) 0.86

Blood-brain barrier and retroviral infections. Virulence (2012) 0.85

Multi-low-dose mucosal simian immunodeficiency virus SIVmac239 challenge of cynomolgus macaques immunized with "hyperattenuated" SIV constructs. J Virol (2009) 0.85

Characterization of simian immunodeficiency virus (SIV) that induces SIV encephalitis in rhesus macaques with high frequency: role of TRIM5 and major histocompatibility complex genotypes and early entry to the brain. J Virol (2014) 0.84

Older rhesus macaque infants are more susceptible to oral infection with simian-human immunodeficiency virus 89.6P than neonates. J Virol (2005) 0.84

Growth regulation of simian and human AIDS-related non-Hodgkin's lymphoma cell lines by TGF-beta1 and IL-6. BMC Cancer (2007) 0.83

Viral genetic evolution in macaques infected with molecularly cloned simian immunodeficiency virus correlates with the extent of persistent viremia. J Virol (1998) 0.82

Liver disease in rhesus monkeys infected with simian immunodeficiency virus. Am J Pathol (1991) 0.81

Virus-associated lymphomagenesis. Int J Biomed Sci (2006) 0.79

Role for cFMS in maintaining alternative macrophage polarization in SIV infection: implications for HIV neuropathogenesis. J Neuroinflammation (2015) 0.79

Genetic variation at the mitochondrial large-subunit rRNA locus of Pneumocystis isolates from simian immunodeficiency virus-infected rhesus macaques. Clin Diagn Lab Immunol (2003) 0.78

Behavioral, Metabolic, and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model. J Neuroimmune Pharmacol (2015) 0.77

Correction of a carboxyl terminal simian immunodeficiency virus Nef frameshift mutation restores virus replication in macaques. Virology (2010) 0.75

Pathogenesis of oral FIV infection. PLoS One (2017) 0.75

A SIV molecular clone that targets the CNS and induces neuroAIDS in rhesus macaques. PLoS Pathog (2017) 0.75

Cytomegaloviral hypophysitis in a simian immunodeficiency virus-infected rhesus macaque (Macacca mulatta). J Med Primatol (2017) 0.75

Articles by these authors

Localization of cystic fibrosis locus to human chromosome 7cen-q22. Nature (1985) 7.77

An African primate lentivirus (SIVsm) closely related to HIV-2. Nature (1989) 5.03

Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature (1986) 4.35

Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat Med (1999) 3.86

A formalin-inactivated whole SIV vaccine confers protection in macaques. Science (1989) 3.37

SIV adaptation to human cells. Nature (1989) 3.09

Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science (1996) 2.65

Distemper Studies in Ferrets-Part II: II. Tissue Vaccines prepared from Viscerotropic Distemper Virus. Can J Comp Med Vet Sci (1942) 2.46

Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc Natl Acad Sci U S A (1997) 2.34

Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J Virol (1997) 2.34

Brief report: infection of a laboratory worker with simian immunodeficiency virus. N Engl J Med (1994) 2.32

Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J Virol (2000) 2.26

Distemper Studies in Ferrets-Part IV: IV.Protective, Therapeutic and Aggressin Properties of Composite Tissue Vaccine. Can J Comp Med Vet Sci (1942) 2.03

Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J Virol (1995) 2.01

Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J Virol (1997) 1.86

Simian immunodeficiency virus/delta-induced immunodeficiency disease in rhesus monkeys: relation of antibody response and antigenemia. J Infect Dis (1988) 1.75

Characterization of a novel simian immunodeficiency virus (SIV) from L'Hoest monkeys (Cercopithecus l'hoesti): implications for the origins of SIVmnd and other primate lentiviruses. J Virol (1999) 1.75

Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am J Pathol (1997) 1.63

Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain. Virology (2001) 1.52

Species-specific variation in SIV disease progression between Chinese and Indian subspecies of rhesus macaque. J Med Primatol (2002) 1.46

Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally. J Virol (1995) 1.39

Epstein-Barr virus-related herpesvirus from a rhesus monkey (Macaca mulatta) with malignant lymphoma. Int J Cancer (1986) 1.38

Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections. J Virol (1998) 1.38

Studies on the secretory immunologic system of fowl. 3. Serum and secretory IgA of the chicken. J Immunol (1973) 1.37

Effects of initiation of 3'-azido,3'-deoxythymidine (zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus. J Infect Dis (1993) 1.35

Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J Virol (1998) 1.30

Transmissible lymphoma and simian acquired immunodeficiency syndrome in rhesus monkeys. J Natl Cancer Inst (1986) 1.23

Efficacy of SIV/deltaB670 glycoprotein-enriched and glycoprotein-depleted subunit vaccines in protecting against infection and disease in rhesus monkeys. AIDS (1991) 1.23

Comparison of simian immunodeficiency virus and human immunodeficiency virus encephalitides in the immature host. Ann Neurol (1988) 1.22

Production and characterization of SIV envelope-specific rhesus monoclonal antibodies from a macaque asymptomatically infected with a live SIV vaccine. AIDS Res Hum Retroviruses (1998) 1.20

Epidemiology of rob beta-lactamase among ampicillin-resistant Haemophilus influenzae isolates in the United States. J Infect Dis (1988) 1.19

Evolution of a simian immunodeficiency virus pathogen. J Virol (1998) 1.15

AIDS vaccine developments. Nature (1992) 1.15

Distribution of SIV in lymph nodes of serially sacrificed rhesus monkeys. AIDS Res Hum Retroviruses (1995) 1.15

Experimental microsporidiosis in immunocompetent and immunodeficient mice and monkeys. Folia Parasitol (Praha) (1994) 1.15

The replicative capacity of rhesus macaque peripheral blood mononuclear cells for simian immunodeficiency virus in vitro is predictive of the rate of progression to AIDS in vivo. J Gen Virol (2000) 1.12

Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines. J Immunol (2000) 1.12

Targeted integration of baboon endogenous virus in the BEVI locus on human chromosome 6. Nature (1983) 1.11

Thymus in simian immunodeficiency virus-infected rhesus monkeys. Lab Invest (1991) 1.10

Serial pathogenesis study of SIV brain infection. J Med Primatol (1991) 1.10

Experimental leprosy in three species of monkeys. Science (1985) 1.09

Distemper Studies in Ferrets-Part VI: VI. Attempted Control of a Distem per Epidemic in a Ferret Colony with Tissue Va ccines and with Anti-serum. Can J Comp Med Vet Sci (1942) 1.08

SIV/DeltaB670 transmission across oral, colonic, and vaginal mucosae in the macaque. J Med Primatol (1997) 1.07

Structure and function of serum and membrane immunoglobulin D (IgD). Contemp Top Mol Immunol (1978) 1.06

Lentivirus-induced pulmonary lesions in rhesus monkeys (Macaca mulatta) infected with simian immunodeficiency virus. Vet Pathol (1991) 1.05

Immunodeficiency and lymphoproliferative disease in an African green monkey dually infected with SIV and STLV-I. AIDS Res Hum Retroviruses (1992) 1.04

Correlates of SIV encephalitis in rhesus monkeys. J Med Primatol (1992) 1.03

Depression of lymphocyte responses to mitogens in mangabeys with disseminated experimental leprosy. Cell Immunol (1985) 1.03

Lymphocyte surface IgD and IgM in non-human primates. Int Arch Allergy Appl Immunol (1976) 1.00

Functional analysis of monkey lymphocyte subsets defined by OKT4 and OKT8 Monoclonal Antibodies. Cell Immunol (1983) 0.99

Oral transmission of primate lentiviruses. J Infect Dis (1999) 0.99

Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein. J Virol (1994) 0.99

Tracking members of the simian immunodeficiency virus deltaB670 quasispecies population in vivo at single-cell resolution. J Virol (1998) 0.98

Multidrug chemotherapy of tuberculosis in rhesus monkeys. Lab Anim Sci (1988) 0.98

Chromatographic fractionation of rhesus monkey (Macaca mulatta) IgG subclasses using deae cellulose and protein A-sepharose. J Immunol Methods (1982) 0.97

Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV. Immunol Cell Biol (1997) 0.96

Generalized amyloidosis in rhesus monkeys. Vet Pathol (1986) 0.96

In vitro ethanol suppresses alveolar macrophage TNF-alpha during simian immunodeficiency virus infection. Am J Respir Crit Care Med (2000) 0.95

Induction of immunodeficiency virus-specific immune responses in rhesus monkeys following gene gun-mediated DNA vaccination. J Med Primatol (1996) 0.95

Genotypic analysis of infant macaques infected transplacentally and orally. J Med Primatol (1996) 0.94

Distemper Studies in Foxes: VI. - Attempted Immunization of Foxes with Ferret Distemper Virus Against Canine Distemper Virus. Can J Comp Med Vet Sci (1944) 0.94

Effect of mycobacterial infection on virus loads and disease progression in simian immunodeficiency virus-infected rhesus monkeys. AIDS Res Hum Retroviruses (2000) 0.93

Herpesvirus saimiri-induced malignant lymphoma in rabbits. J Natl Cancer Inst (1976) 0.92

Oral SIV, SHIV, and HIV type 1 infection. AIDS Res Hum Retroviruses (1998) 0.92

Simian AIDS-associated lymphoma in rhesus and cynomolgus monkeys recapitulates the primary pathobiological features of AIDS-associated non-Hodgkin's lymphoma. AIDS Res Hum Retroviruses (1999) 0.92

IgM-forming cells as the immediate precursor of IgA-producing cells during ontogeny of the immunoglobulin-producing system of the chicken. J Immunol (1974) 0.92

Experimental infection of timed-pregnant rhesus monkeys with simian immunodeficiency virus (SIV) during early, middle, and late gestation. J Med Primatol (1990) 0.91

Immunology of pyelonephritis in the primate model: live versus heat-killed bacteria. Kidney Int (1981) 0.91

Secretory immunological system of fowl. V. The gallbladder: an integral part of the secretory immunological system of fowl. Int Arch Allergy Appl Immunol (1976) 0.91

Neonatal disease induced by SIV infection of the rhesus monkey (Macaca mulatta). AIDS Res Hum Retroviruses (1993) 0.91

A model for the maturation of protective antibody responses to SIV envelope proteins in experimentally immunized monkeys. J Med Primatol (1997) 0.91

Squamous epithelial proliferative lesions associated with rhesus Epstein-Barr virus in simian immunodeficiency virus-infected rhesus monkeys. J Infect Dis (1995) 0.90

Identification of SIV env-specific CTL in the jejunal mucosa in vaginally exposed, seronegative rhesus macaques (Macaca mulatta). J Med Primatol (2000) 0.90

Experimental leprosy in monkeys. I. Sooty mangabey monkeys: transmission, susceptibility, clinical and pathological findings. Lepr Rev (1995) 0.90

Rhesus rhadinovirus infection in healthy and SIV-infected macaques at Tulane National Primate Research Center. J Med Primatol (2003) 0.90

Rhesus lymphocryptovirus infection during the progression of SAIDS and SAIDS-associated lymphoma in the rhesus macaque. AIDS Res Hum Retroviruses (2000) 0.90

Pathogenesis of simian immunodeficiency virus pneumonia: an immunopathological response to virus. Am J Pathol (1998) 0.89

Simian immunodeficiency virus needlestick accident in a laboratory worker. Lancet (1992) 0.89

Integration of plasmid DNA coding for beta-lactamase production in the Haemophilus influenzae chromosome. J Bacteriol (1984) 0.89

Effects of U-75875, a peptidomimetic inhibitor of retroviral proteases, on simian immunodeficiency virus infection in rhesus monkeys. Antimicrob Agents Chemother (1994) 0.88

Age-dependent changes in T cell homeostasis and SIV load in sooty mangabeys. J Med Primatol (2000) 0.88

Ontogeny of IgA in normal and neonatally bursectomized chickens, with corroborative data on IgY and IgM. Proc Soc Exp Biol Med (1973) 0.88